Carla Gamarra-Hilburn, MD
Rheumatology · New Albany, INNPI 1679861702
Payments from drug & device makers
Across 640 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- UCB, Inc.$789
- GSK$726
- AstraZeneca$540
- E.r. Squibb & Sons, L.L.C.$463
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 169 | $2,992 |
| AbbVie | 130 | $2,430 |
| UCB, Inc. | 42 | $789 |
| GSK | 40 | $726 |
| AstraZeneca(2 entities) | 31 | $540 |
| E.r. Squibb & Sons, L.L.C. | 24 | $463 |
| Novartis | 27 | $413 |
| Lilly USA, LLC | 37 | $406 |
| Pfizer | 21 | $344 |
| Johnson & Johnson(2 entities) | 18 | $307 |
| Genentech USA, Inc. | 12 | $239 |
| Mallinckrodt Hospital Products Inc. | 13 | $239 |
| Mallinckrodt Enterprises LLC | 13 | $190 |
| Boehringer Ingelheim | 7 | $146 |
| Organon | 8 | $116 |
| Bristol Myers Squibb | 6 | $108 |
| Regeneron Healthcare Solutions, Inc. | 5 | $89 |
| Sanofi | 4 | $81 |
| Aurinia Pharma U.S., Inc. | 5 | $77 |
| Pacira Therapeutics, Inc. | 4 | $73 |
| ANI Pharmaceuticals, Inc. | 4 | $66 |
| Fresenius Kabi USA, LLC | 4 | $65 |
| Bioventus LLC | 3 | $44 |
| Merck | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 2 | $35 |
| Radius Health, Inc. | 2 | $31 |
| Invivyd Inc | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| Sandoz | 1 | $14 |
| Medexus Pharma, Inc. | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Janssen Scientific Affairs, LLC | 1 | $7 |
How this compares
$11,136 in reported general payments places this provider in the 80th percentile of 106 rheumatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in New Albany
- Roneka RavenellNew Albany$16K
- Charles Moore JrNew Albany$3K
- Mohsen EhsanNew Albany$2K
- Moges SisayEvansville$1.8M
- David BattIndianapolis$577K
- Kathleen ThomasNoblesville$511K
- Keith ReichDyer$193K
- Douglas SmithIndianapolis$147K
- Ahmad SalahMerrillville$139K
- Inna AroutiounovaIndianapolis$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.